Items where authors include "Gossec, L."

Article

Yazji, S.M., Helliwell, P.S. orcid.org/0000-0002-4155-9105, Balanescu, A. et al. (9 more authors) (2025) Association between patient perception of disease status and different components of the Minimal Disease Activity (MDA) criteria in psoriatic arthritis. The Journal of Rheumatology. ISSN 0315-162X

López-Medina, C., McGonagle, D. and Gossec, L. (2024) Subclinical psoriatic arthritis and disease interception—where are we in 2024? Rheumatology. keae399. ISSN 1462-0324

Zabotti, A. orcid.org/0000-0002-0573-464X, Fagni, F. orcid.org/0000-0002-6122-0774, Gossec, L. orcid.org/0000-0002-4528-310X et al. (15 more authors) (2024) Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage. RMD Open, 10 (2). e004314. ISSN 2056-5933

Coyle, C., Watson, L., Whately-Smith, C. et al. (28 more authors) (2024) How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients. Rheumatology. kead679. ISSN 1462-0324

Unger, J., Putrik, P., Buttgereit, F. et al. (18 more authors) (2018) Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction risk of bias tool and the EULAR points to consider. RMD Open, 4 (2). e000756. ISSN 2056-5933

Conference or Workshop Item

Watson, L., Coyle, C., Brooke, M. et al. (25 more authors) (2023) Current prescribing practices in psoriatic arthritis - comparison between the UK and Europe. In: British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester - Hybrid.

Proceedings Paper

Zabotti, A., De Marco, G. orcid.org/0000-0003-2406-161X, Gossec, L. et al. (26 more authors) (2023) OP0062 EULAR points to consider for the definition of clinical and imaging features suspicious for progression to psoriatic arthritis. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 42-43.

Coyle, C., Watson, L., Brooke, M. et al. (25 more authors) (2023) P174 Psoriatic arthritis patients in the UK have a lower quality of life than patients in mainland Europe - an analysis from the ASSIST study. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

Watson, L.L., Coyle, C., Brooke, M. et al. (25 more authors) (2023) P179 Shared decision-making in psoriatic arthritis consultations. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

Coyle, C., Whately-Smith, C., Brooke, M. et al. (24 more authors) (2022) 1028: How Does PsAID Implementation Affect Treatment Intensification and Patient Satisfaction in PsA? In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 2040-2042.

Yazji, S., Helliwell, P., Balanescu, A. et al. (13 more authors) (2022) 1496: Do Patients in MDA Report Low Disease Activity Regardless of Which of the MDA Criteria Are Met? In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 2954-2957.

Coates, L., Gossec, L., Contre, C. et al. (8 more authors) (2022) 2127: Guselkumab Provides Continued Improvement in Key Domains of Psoriatic Arthritis Through 2 Years. In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 4214-4216.

Coates, L., Gossec, L., Contre, C. et al. (8 more authors) (2022) POS1017 Guselkumab Provides Continued Improvement In Key Domains Of Psoriatic Arthritis Through 2 Years. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 818-819.